Sabby Management, LLC Acurx Pharmaceuticals, Inc. Transaction History
Sabby Management, LLC
- $12.5 Million
- Q1 2025
A detailed history of Sabby Management, LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Sabby Management, LLC holds 2,044,546 shares of ACXP stock, worth $817,818. This represents 6.36% of its overall portfolio holdings.
Number of Shares
2,044,546Holding current value
$817,818% of portfolio
6.36%Shares
1 transactions
Others Institutions Holding ACXP
# of Institutions
27Shares Held
3.49MCall Options Held
100Put Options Held
0-
Vanguard Group Inc Valley Forge, PA529KShares$211,7390.0% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$146,6300.08% of portfolio
-
Geode Capital Management, LLC Boston, MA171KShares$68,5940.0% of portfolio
-
Morgan Stanley New York, NY106KShares$42,4800.0% of portfolio
-
Vanguard Capital Wealth Advisors67.5KShares$27,0000.03% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $4.62M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...